SUPIRA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION AS THE COMPANY CLOSED $40M IN SERIES D FINANCING streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device
/PRNewswire/ Supira Medical, Inc., a Shifamed portfolio company, announced today that the company s percutaneous ventricular assist device (pVAD) will be.
Shifamed Innovation Hub to be Prominently Featured at TCT 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.